Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Kukla
Michael Kukla
Johnson & Johnson Pharmaceutical Research and Development
Virology
Etravirine
Chemical synthesis
Organic chemistry
Enzyme
4
Papers
347
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Etravirine: From TMC125 to Intelence: A Treatment Paradigm Shift for HIV‐Infected Patients
2011
Koen Andries
Ann Debunne
Thomas N. Kakuda
Michael Kukla
Ruud Leemans
Johan Vingerhoets
Brian Woodfall
Marie-Pierre de Béthune
Show All
Source
Cite
Save
Citations (1)
Novel triazole based inhibitors of Ras farnesyl transferase.
2005
Bioorganic & Medicinal Chemistry Letters
Ashis K. Saha
Li Liu
Richard Simoneaux
Bart Decorte
Christophe Meyer
Stacy Skrzat
Henry J. Breslin
Michael Kukla
Dave W. End
Show All
Source
Cite
Save
Citations (18)
TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1
2004
Antimicrobial Agents and Chemotherapy
Koen Andries
Hilde Azijn
Theo Thielemans
Donald Ludovici
Michael Kukla
Jan Heeres
Paul Andriaan Jan Janssen
Bart L. De Corte
Johan Vingerhoets
Rudi Pauwels
Marie-Pierre de Béthune
Show All
Source
Cite
Save
Citations (311)
Tripeptidyl-peptidase II (TPP II) inhibitory activity of (S)-2,3-dihydro-2-(1H-imidazol-2-yl)-1H-indoles, a systematic SAR evaluation. Part 2.
2003
Bioorganic & Medicinal Chemistry Letters
Henry J. Breslin
Tamara A. Miskowski
Michael Kukla
Hans L. De Winter
Maria V.F. Somers
Peter Walter Maria Roevens
Robert W. Kavash
Show All
Source
Cite
Save
Citations (17)
1